Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ELACESTRANT DIHYDROCHLORIDE

02 1TAGRAXOFUSP-ERZS

03 1Tagraxofuspum

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : ORSERDU

Antibody Engineering
Not Confirmed
arrow

Brand Name : ORSERDU

arrow
Antibody Engineering
Not Confirmed

Stemline Therapeutics

Dosage Form : TABLET;ORAL

Brand Name : ORSERDU

Dosage Strength : EQ 86MG BASE

Packaging :

Approval Date : 2023-01-27

Application Number : 217639

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : ORSERDU

Antibody Engineering
Not Confirmed
arrow

Brand Name : ORSERDU

arrow
Antibody Engineering
Not Confirmed

Stemline Therapeutics

Dosage Form : TABLET;ORAL

Brand Name : ORSERDU

Dosage Strength : EQ 345MG BASE

Packaging :

Approval Date : 2023-01-27

Application Number : 217639

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : ELZONRIS

Antibody Engineering
Not Confirmed
arrow

Brand Name : ELZONRIS

arrow
Antibody Engineering
Not Confirmed

Stemline Therapeutics

Dosage Form : SOLUTION;INJECTION

Brand Name : ELZONRIS

Dosage Strength : 1000MCG

Packaging :

Approval Date :

Application Number : 761116

Regulatory Info :

Registration Country : USA

blank

04

Brand Name : Elzonris

Antibody Engineering
Not Confirmed
arrow

Brand Name : Elzonris

arrow
Antibody Engineering
Not Confirmed

Stemline Therapeutics

Dosage Form : Inf Conc

Brand Name : Elzonris

Dosage Strength : 1mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank